Objectives This subanalysis of the CASTLE-AF (Catheter Ablation vs. Standard
Conventional Treatment in Patients With LV Dysfunction and AF) trial aimed to address the …

Background: Recent data demonstrate promising effects on left ventricular dysfunction and
left ventricular ejection fraction (LVEF) improvement following ablation for atrial fibrillation …

Background: Optimal treatment of patients with persistent atrial fibrillation (AF) and heart
failure (HF) with reduced left ventricular ejection fraction (LVEF) and an indication for …

Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …

Background Mortality and morbidity are higher among patients with atrial fibrillation and
heart failure than among those with heart failure alone. Catheter ablation for atrial fibrillation …

Background In the Catheter Ablation for Atrial Fibrillation with Heart Failure (CASTLE-AF)
trial, catheter ablation reduced the risk of death and heart failure (HF) hospitalization in …

Objectives: The objective of the study was to compare rate control versus atrial fibrillation
(AF) catheter ablation strategies in patients with AF and heart failure (HF). Background …

Objectives: This study sought to compare catheter ablation with rate control for persistent
atrial fibrillation (AF) in heart failure (HF). Background: The optimal therapy for AF in HF is …

Background—Restoring sinus rhythm in patients with heart failure (HF) and atrial fibrillation
(AF) may improve left ventricular (LV) function and HF symptoms. We sought to compare the …

Atrial fibrillation and heart failure with reduced ejection fraction are increasing in prevalence
worldwide. Atrial fibrillation can precipitate and can be a consequence of heart failure with …